Region: International

It is time for life sciences IP professionals to embrace change in the industry

Opinion: Pharma and biotech patent professionals must adapt to new challenges and opportunities

13 May 2023

Report urges companies to hunt for more value from their patents

PatSnap’s “State of IP” report reveals intelligence about patent value, monetisation strategies, IP department budgets and more

11 May 2023

Cellular patent pools: a prescription for success

Alium offers its perspective on what makes some joint licensing programmes flourish over others

10 May 2023

Qualcomm licensing woes deepened by ongoing handset headwinds

The company’s per-device licensing approach has rendered it especially vulnerable to severe drop offs in smartphone sales

04 May 2023

Xiaomi, Meta and Sisvel to speak at IPBC Global 2023

IP industry leaders will come together in San Diego in June to share their insight and experience

27 April 2023

Patent cliff concerns drive Merck’s $11 billion Prometheus buyout

Deal hoped to stave off investor concerns about expiring patents and diversify product pipeline

20 April 2023

The brokered patent market in 2022

Featured in Secondary Market Activity

The 2023 Richardson Oliver Patent Market Report gives a snapshot of 2022 buy-sell activity, including sourcing, diligence, pricing, buyers, litigation and market size

19 April 2023

Bristol-Myers Squibb and Dana-Farber settle landmark dispute

Here's what you should know about the parties’ long-running battle over lucrative immuno-therapy patents

13 April 2023

Patent transactions in Q4 2022

Featured in Secondary Market Activity

Allied Security Trust’s Patent Deals Report shows overall transactions last year dropped on 2021, although the figures are less stark when compared to pre-covid years

11 April 2023

New Pfizer/BioNTech covid-19 lawsuit adds to complex web of mRNA disputes

Genevant and Arbutus are seeking to cash in with another legal action targeting best-selling jab makers

11 April 2023